Top Manufacturers and Suppliers for Teva
Discover the Top Manufacturers and Suppliers for Teva with SourceReady, leveraging AI and data from over 40 sources to enhance your product sourcing.
Teva ManufacturersTeva SuppliersProduct SourcingAI Sourcing
Actavis Limited
🇲🇹 Malta
1001-2000 peopleManufacturerHigh capacity factory
Large enterprise group
Multinational enterprise
OEM manufacturer
Shipments
12285
Key customer
TEVA
Key market
🇷🇺 Russia
Description
Actavis Limited, based in Zejtun, Malta, is a prominent manufacturer and OEM service provider specializing in the pharmaceutical industry. As part of a global network with over a century of history, the company operates a large-scale facility employing between 1,001 and 2,000 professionals. Actavis Limited focuses on the production of a comprehensive portfolio of medicines, including generic medicines, specialty medicines, and biopharmaceuticals. Their specific product expertise encompasses medicaments such as sartans, statins, and prils, contributing to a global supply chain that serves approximately 200 million people daily. The company maintains a strong international trade presence, exporting pharmaceutical products to key markets across Europe, North America, and Asia. Actavis Limited is committed to making healthcare more accessible while adhering to rigorous standards in ESG progress, transparency, and accountability.
TEVA RUNCORN
🇬🇧 United Kingdom
201-300 peopleManufacturer/Distributor/Service CompanyOEM manufacturer
Multinational enterprise
Experienced exporter
Multi-country export
Shipments
752
Key customer
TEVA
Key market
🇺🇸 United States
Description
TEVA RUNCORN is a contract manufacturer, manufacturer, distributor, and service company based in Runcorn, GB, operating as part of the global Teva biopharmaceutical company with over 120 years of operation. The company employs between 201 and 300 people and specializes in the manufacturing and distribution of pharmaceutical products, including generic medicines, specialty medicines, biopharmaceuticals, and sterile products. They are a key partner for the NHS in the UK, committed to providing quality medicines and improving healthcare. TEVA RUNCORN's product portfolio addresses various therapeutic areas such as Central Nervous System, Migraine, Respiratory, Oncology, Pain, and Consumer Health. The Runcorn site is involved in manufacturing and packaging, including work with pre-fill syringes. The company also produces vitamins and provitamins and is dedicated to sustainability through its "Healthy Future" strategy. They operate as a responsible business in a regulated environment, adhering to recognized industry standards for quality and safety.
SynZeal Research Private Limited
🇮🇳 India
2010101-200 peopleManufacturer/Service Company/DistributorHigh-tech enterprise
Experienced exporter
Multi-country export
Shipments
62950
Key customer
TEVA
Key market
🇧🇷 Brazil
Description
SynZeal Research Private Limited is a research-driven manufacturer and CDMO/CRO partner headquartered in Ahmedabad, India. Established as a leader in the pharmaceutical industry, the company operates a specialized R&D facility and a factory focused on cGMP API production. With a workforce of 101 to 200 employees, SynZeal provides comprehensive chemistry research services to support drug discovery and development globally. The company maintains a vast catalog of over 15,000 products, specializing in high-purity pharmaceutical reference standards, API impurities, stable isotope-labelled compounds, and drug metabolites. Their technical expertise extends to the custom synthesis of synthetic peptides, heterocycles, nucleosides, and secondary reference standards. SynZeal is committed to international quality standards, holding certifications including ISO 9001:2015, ISO 17025, and ISO 17034, alongside DSIR recognition for their research and development excellence.
Piramal Pharma Limited
🇮🇳 India
More than 10000 peopleManufacturer/Service Company/DistributorHigh capacity factory
Large enterprise group
OEM manufacturer
Multinational enterprise
Shipments
14258
Key customer
TEVA
Key market
🇺🇸 United States
Description
Piramal Pharma Limited is a leading global pharmaceutical conglomerate headquartered in Mumbai, India, with a workforce exceeding 10,000 employees. Operating as a premier Contract Development and Manufacturing Organization (CDMO), the company provides end-to-end drug life cycle solutions, including drug discovery, API development, and commercial manufacturing. Its extensive manufacturing network spans North America, Europe, and Asia, featuring facilities that adhere to rigorous international standards including USFDA, PMDA, EMA, MHRA, and WHO-GMP certifications.
How can I send inquiries to multiple suppliers?
You can select multiple suppliers and send inquiries in bulk. SourceReady helps structure the outreach process so you can contact several manufacturers at once, collect responses, and compare quotes more efficiently.
Teva Pharmaceutical Industries Ltd.
🇮🇱 Israel
1935More than 10000 peopleManufacturerHigh capacity factory
Established brand
Large enterprise group
Own brand
Shipments
2535
Key customer
TEVA
Key market
🇮🇳 India
Description
Teva Pharmaceutical Industries Ltd. is a leading global biopharmaceutical company headquartered in Tel Aviv, Israel, with a history spanning over 120 years. As the world's largest manufacturer of generic medicines, the company operates a vast global supply chain with manufacturing facilities across Israel, North America, Europe, Australia, and South America. Teva specializes in a diverse portfolio that includes complex generics, biosimilars, active pharmaceutical ingredients (APIs), and innovative branded pharmaceuticals. Its core therapeutic areas of expertise encompass neuroscience, oncology, respiratory, immunology, and pain care, with notable branded products such as Copaxone for multiple sclerosis and Austedo for movement disorders. The company is a major player in the global healthcare market, employing over 30,000 people and maintaining FDA-approved production sites. Beyond its extensive product catalog, Teva provides contract manufacturing (OEM) and out-licensing services. The company is committed to innovation through its R&D pipeline and the 'Rise' global open innovation platform, which focuses on AI, Industry 4.0, and smart manufacturing to accelerate drug development and delivery. Teva is publicly traded on both the New York Stock Exchange (NYSE) and the Tel Aviv Stock Exchange (TASE).
FDC Limited
🇮🇳 India
19365001-10000 peopleManufacturerHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
6486
Key customer
TEVA
Key market
🇳🇵 Nepal
Description
FDC Limited is a vertically integrated global pharmaceutical manufacturer headquartered in Mumbai, India. Established in 1936, the company is ranked among India’s top 25 pharmaceutical players, employing over 7,000 people and maintaining a significant international presence across 50 countries. The company operates multiple USFDA-approved manufacturing plants and holds GMP and ISO certifications, specializing in both Active Pharmaceutical Ingredients (API) and Finished Dosage Forms.
As a leading CDMO/CMO for API and Finished Dosage Formulation, the company provides comprehensive contract manufacturing services. Its specialized capabilities include the production of generic APIs such as Peptides and Prostaglandins, as well as a diverse range of formulations including capsules, creams, lotions, ointments, drops, syrups, and tablets. The company is a market leader in Oral Rehydration Salts (ORS) and electrolyte beverages, offering flavoured ORS powders, antioxidant blends, and protein-fortified drinks.
FDC Limited serves a wide array of therapeutic segments, including ophthalmic therapies, anti-infectives, gastrointestinal, cardiovascular, anti-diabetic, gynaecology, and dermatology. Their technical expertise extends to specialized oral liquids, ophthalmic drops, and topical preparations, supported by robust R&D for specialty and generic drug manufacturing. The company is publicly traded on the NSE and continues to expand its global footprint through in-licensing and out-licensing opportunities.
PT Actavis Indonesia
🇮🇩 Indonesia
1968201-300 peopleManufacturerEstablished brand
ODM manufacturer
OEM manufacturer
Multi-country export
Shipments
605
Key customer
TEVA
Key market
🇸🇬 Singapore
Description
PT Actavis Indonesia is a premier pharmaceutical manufacturer established in 1968 and headquartered in Jakarta. Operating as a key production hub within the Teva Group, the company employs approximately 258 professionals and maintains a robust manufacturing infrastructure with multiple certified facilities. The company specializes in the development and commercialization of generic drugs, innovative specialty pharmaceuticals, and Active Pharmaceutical Ingredients (API). Its extensive therapeutic portfolio covers CNS disorders, gastroenterology, women's health, cardiovascular health, oncology, and anti-infectives.
The company's specialized production capabilities include pharmaceutical enema production (Diazepam 5mg/2.5ml), syrup and suspension formulation in both 3.8L bulk and 60ml retail formats, and the manufacturing of tablets and capsules. They utilize high-grade materials such as Chlorpheniramine Maleate EP grade, Naproxen Sodium USP grade, and Diphenhydramine Hydrochloride BP/EP, alongside specialized chemicals like Ammonium Chloride, Menthol Crystals, and Sodium Citrate Crystals. PT Actavis Indonesia also produces rigid PVC film 250 mic for pharmaceutical packaging and manages complex supply chains involving pneumatic seal roll out systems and specialized temperature sensors.
Committed to international quality standards, the company holds an impressive array of certifications including US-FDA, EU-GMP, Japan-PMDA, and BRAZIL-ANVISA, as well as ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. With a strong R&D focus on production capability enhancement and medical affairs management, the company serves as a critical OEM partner and exporter, distributing high-quality medicaments, antibiotics, and alkaloids to global markets.
Alembic Pharmaceuticals, Inc.
🇺🇸 United States
19075001-10000 peopleManufacturerHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
23820
Key customer
TEVA
Key market
🇺🇸 United States
Description
Alembic Pharmaceuticals, Inc. is a vertically integrated pharmaceutical manufacturer established in 1907, with its U.S. headquarters in Bedminster, New Jersey. Employing over 8,000 professionals, the company specializes in the development and production of active pharmaceutical ingredients (APIs) and complex finished dosage formulations. The organization operates seven manufacturing facilities, including 3 API manufacturing plants and 4 formulation manufacturing plants, all of which are US FDA and MHRA-approved. Their specialized capabilities include vertical integration from API to finished dosage formulation and the development of difficult-to-produce pharmaceutical products. The company's extensive portfolio features oral tablets and capsules (immediate and extended release), topical gels, creams, ointments, ophthalmic solutions, and oncology injectables. With 273 ANDA filings and 143 DMF filings, the company serves critical healthcare sectors including urinary tract infection (UTI) treatments and high-value oncology and ophthalmic care. Note: While the name is shared with a Causal AI platform, this entity is strictly focused on pharmaceutical manufacturing and R&D.
The United States Pharmacopeial Convention
🇺🇸 United States
1001-2000 peopleService CompanyMultinational enterprise
Large enterprise group
Experienced exporter
Multi-country export
Shipments
210512
Key customer
TEVA
Key market
🇮🇳 India
Description
The United States Pharmacopeial Convention is a non-profit scientific organization and service company based in Rockville, US, specializing in science-based quality standards and solutions for the pharmaceutical lifecycle. The organization provides USP-NF compendial monographs in English, Spanish, and French, as well as over 3,500 reference standards and pharmaceutical analytical impurities (PAI). Its standards cover small molecule medicines, complex biologics—including cell/gene/tissue, monoclonal antibodies, and vaccines—excipients, dietary supplements, herbal medicines, and food ingredients. Specialized services include ingredient verification for APIs and excipients, GMP audit programs, dietary supplement verification, and technical guidance for pharmaceutical continuous manufacturing. The organization also offers dissolution and performance verification testing (PVT) support, reference standards technical services for storage and safety data sheets, and monograph modernization. With an ISO accredited quality policy, the organization operates global facilities across the US, Brazil, China, Ghana, India, Kenya, Singapore, and Switzerland.
Dr. Reddy's Laboratories Ltd.
🇮🇳 India
1984More than 10000 peopleManufacturer/Trading Company/Service CompanyHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
58412
Key customer
TEVA
Key market
🇺🇸 United States
Description
Dr. Reddy's Laboratories Ltd. is a prominent Indian multinational pharmaceutical company headquartered in Hyderabad, India, with a global presence including U.S. headquarters in New Jersey. Founded in 1984, the company has grown into a major industry player employing over 24,000 people and maintaining listings on the NSE, BSE, and NYSE. As an integrated pharmaceutical firm, it operates as a manufacturer, trading company, and service provider, specializing in Active Pharmaceutical Ingredients (APIs), generic drugs, biosimilars, and proprietary formulations.
The company's extensive product portfolio encompasses over 190 medications and 60 APIs, covering critical therapeutic areas such as oncology, gastroenterology, cardiovascular health, diabetes, dermatology, and pain management. Notable products include Omeprazole, Ibuprofen, Atorvastatin, and various monoclonal antibodies. Dr. Reddy's also produces vaccines, biologics, and dietary supplements, and has recently expanded into direct-to-consumer e-commerce platforms for specialized wellness products.
With a strong commitment to quality and innovation, the company operates multiple FDA-inspected and ISO 9001/14001 certified manufacturing facilities across India and the UK. Their business model is supported by robust R&D capabilities through the Dr. Reddy's Research Foundation and international laboratories focused on novel therapeutics. The company serves a diverse global clientele, including major pharmaceutical firms like Novo Nordisk and Merck & Co., and provides contract manufacturing (OEM) and discovery services through its Aurigene Pharmaceutical Services segment.
FAQ
How many suppliers does SourceReady track globally?
Can I search for suppliers using one sentence?
How does SourceReady’s AI supplier search work?
